Next Article in Journal
Validation of Energy and Nutrition Intake in Japanese Elderly Individuals Estimated Based on a Short Food Frequency Questionnaire Compared against a 7-day Dietary Record: The Kyoto-Kameoka Study
Previous Article in Journal
Validation of the Japanese Version of the Yale Food Addiction Scale 2.0 (J-YFAS 2.0)

Nutrients 2019, 11(3), 680; https://doi.org/10.3390/nu11030680

Correction
Correction: Billeaud et al. “Effects on Fatty Acid Metabolism of a New Powdered Human Milk Fortifier Containing Medium-Chain Triacylglycerols and Docosahexaenoic Acid in Preterm Infants” Nutrients 2018, 10, 690
1
CIC Pédiatrique 1401 CHU, 33000 Bordeaux, France
2
ITERG, Université de Bordeaux, 33076 Bordeaux, France
3
Nestlé Health Sciences, 1066 Epalinges, Switzerland
4
Nestlé Research Centre, 1000 Lausanne, Switzerland
5
Nestlé Nutrition R&D, 1800 Vevey, Switzerland
6
Department of Neonatology, University of Liège, 4000 Liège, Belgium
7
Hôpital de la Croix Rousse, Hospices Civils, 69004 Lyon, France
8
Hôpital Clocheville, CHU de Tours, 37004 Tours, France
*
Author to whom correspondence should be addressed.
Received: 6 March 2019 / Accepted: 7 March 2019 / Published: 22 March 2019
The authors wish to make a correction to the published version of their paper [1]. While replying to a Letter to the Editor [2], we re-examined our results and realized that an erroneous version of Table 4 had been accidentally incorporated into the paper. During the manuscript review process, we were asked to reorder the table columns, include the standard deviations, and include all of the p values. Due to the substantial nature of these edits, many errors were accidentally introduced into this table. We sincerely apologize for this unfortunate error and regret any subsequent confusion. A corrected version of Table 4 is below.
This change does not impact the overall results or scientific conclusions. The original manuscript will remain online on the article webpage, with a reference to this correction.

References

  1. Billeaud, C.; Boué-Vaysse, C.; Couëdelo, L.; Steenhout, P.; Jaeger, J.; Cruz-Hernandez, C.; Ameye, L.; Rigo, J.; Picaud, J.C.; Saliba, E.; et al. Effects on fatty acid metabolism of a new powdered human milk fortifier containing medium-chain triacylglycerols and docosahexaenoic acid in preterm infants. Nutrients 2018, 10, 690. [Google Scholar] [CrossRef] [PubMed]
  2. Bernhard, W.; Poets, C.F.; Franz, A.R. Letter to the Editor Re: Billeaud et al. Nutrients 2018, 10, 690. Nutrients 2019, 11, 103. [Google Scholar] [CrossRef] [PubMed]
Table 4 (Corrected). Fatty acid profile (g/100 g of fatty acids) of total plasma phospholipids in preterm infants, receiving human milk fortified with a control (cHMF) or with a new human milk fortifier (nHMF) before and after 21 days of treatment. Estimates of the treatment effect nHMF/cHMF (difference) and the two-sided p-values are given for each fatty acid analyzed in the different lipid compartments.
Table 4 (Corrected). Fatty acid profile (g/100 g of fatty acids) of total plasma phospholipids in preterm infants, receiving human milk fortified with a control (cHMF) or with a new human milk fortifier (nHMF) before and after 21 days of treatment. Estimates of the treatment effect nHMF/cHMF (difference) and the two-sided p-values are given for each fatty acid analyzed in the different lipid compartments.
cHMF (n = 21)nHMF (n = 26)
BaselineAfter 21 DaysBaselineAfter 21 DaysDifferencep Value
MeanSDMeanSDMeanSDMeanSD
14:00.210.140.220.140.240.130.260.130.1840.500
15:00.130.100.180.260.140.080.120.03−0.0710.722
16:025.005.5522.756.2126.003.5826.462.760.1800.020
16:0 DMA0.630.180.700.170.640.160.740.27−0.1340.394
16:1 n-71.240.711.051.191.280.690.930.700.2090.188
16:1 n-90.320.140.240.150.300.120.250.130.2190.117
18:014.992.9017.254.1514.511.6515.841.63−0.0600.203
18:0 DMA0.330.120.470.370.350.100.360.14−0.4020.040
18:1 DMA0.290.140.320.110.300.090.300.13−0.2880.054
18:1 n-73.070.592.360.623.050;892.590.770.1220.015
18:1 n-914.042.1611.983.3713.903.0312.452.970.0510.286
trans-18:10.300.150.420.160.390.130.400.17−0.1120.515
18:2 n-6 (LA)12.903.2014.602.5314.032.7514.692.550.0430.452
18:3 n-3 (ALA)0.180.140.110.050.180.100.170.080.2190.125
18:3 n-6 (GLA)0.220.070.170.060.220.060.160.040.0300.689
20:00.360.290.400.310.380.210.410.180.0110.945
20:1 n-90.250.080.310.090.270.100.360.120.1560.072
20:2 n-60.470.130.670.460.510.110.530.10−0.1120.340
20:3 n-6 (DGLA)3.790.894.041.053.460.723.450.68−0.1610.041
20:3 n-92.561.461.901.532.121.192.111.510.0890.612
20:4 n-6 (ARA)9.812.3310.633.549.092.038.262.58−0.2110.015
20:5 n-3 (EPA)0.840.480.700.250.880.320.970.280.3180.006
22:00.460.390.530.530.530.330.570.270.1100.567
22:1 n-90.050.030.050.030.050.020.050.020.0480.676
22:4 n-60.460.170.490.290.400.130.350.10−0.2570.032
22:5 n-3 (n-3 DPA)0.460.240.530.310.440.120.400.12−0.2170.037
22:5 n-6 (n-6 DPA)0.490.190.530.250.450.250.500.22−0.0050.970
22:6 n-3 (DHA)3.601.423.961.943.220.933.541.04−0.0500.575
24:00.390.290.530.800.480.280.430.18−0.0560.742
24:1 n-91.501.231.470.831.550.981.770.730.1910.368
Data are presented as geometric mean and geometric standard deviation (SD). ALA, α-linolenic acid; ARA, arachidonic acid; DGLA, dihomo-γ-linolenic acid; DHA, docosahexaenoic acid; DMA, dimethyl acetal; DPA, docosapentaenoic acid; EPA, eicosapentaenoic acid; GLA, γ-linolenic acid; LA, linoleic acid.

© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Back to TopTop